3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-Month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients With Uterine Fibroids.

Trial Profile

3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-Month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients With Uterine Fibroids.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Aug 2013

At a glance

  • Drugs Leuprorelin (Primary)
  • Indications Uterine leiomyoma
  • Focus Pharmacokinetics
  • Sponsors Takeda Pharma
  • Most Recent Events

    • 08 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top